| pubmed-article:8308770 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0003323 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0003211 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
| pubmed-article:8308770 | lifeskim:mentions | umls-concept:C0487019 | lld:lifeskim |
| pubmed-article:8308770 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:8308770 | pubmed:dateCreated | 1994-3-17 | lld:pubmed |
| pubmed-article:8308770 | pubmed:abstractText | Cell surface molecules can be shed by activated T lymphocytes and measured in serum to assess in vivo T cell activation. To evaluate the relationship between these serum markers and disease activity in rheumatoid arthritis (RA), we determined levels of soluble interleukin 2 receptor (sIL-2R), CD4 (sCD4), and CD8 (sCD8) in sera from a well characterized group of 26 patients with active RA treated with a nonsteroidal antiinflammatory drug (NSAID) alone. | lld:pubmed |
| pubmed-article:8308770 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8308770 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8308770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8308770 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8308770 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:8308770 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:8308770 | pubmed:author | pubmed-author:LipskyP EPE | lld:pubmed |
| pubmed-article:8308770 | pubmed:author | pubmed-author:PisetskyD SDS | lld:pubmed |
| pubmed-article:8308770 | pubmed:author | pubmed-author:CushJ JJJ | lld:pubmed |
| pubmed-article:8308770 | pubmed:author | pubmed-author:DawsonD VDV | lld:pubmed |
| pubmed-article:8308770 | pubmed:author | pubmed-author:DooleyM AMA | lld:pubmed |
| pubmed-article:8308770 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8308770 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:8308770 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8308770 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8308770 | pubmed:pagination | 1857-62 | lld:pubmed |
| pubmed-article:8308770 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:meshHeading | pubmed-meshheading:8308770-... | lld:pubmed |
| pubmed-article:8308770 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8308770 | pubmed:articleTitle | The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8. | lld:pubmed |
| pubmed-article:8308770 | pubmed:affiliation | Department of Medicine, Duke University Medical Center, Durham, NC. | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8308770 | pubmed:publicationType | Multicenter Study | lld:pubmed |
